한방비만학회지 (Journal of Korean Medicine for Obesity Research)

  • 제17권1호
  • /
  • Pages.54-60
  • /
  • 2017
  • /
  • 1976-9334(pISSN)
  • /
  • 2288-1522(eISSN)
한방비만학회 (The Society of Korean Medicine for obesity Research)
권호 표지
DOI QR코드

DOI QR Code

한방비만치료가 비만환자의 간기능에 미치는 영향 증례보고

Effects of the Obesity Therapy with Korean Herbal Medicine on Liver Function: Case Series

  • 투고 : 2017.05.18
  • 심사 : 2017.06.08
  • 발행 : 2017.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

비만을 주소증으로 내원하여 LFT를 시행하고, 한약 치료를 포함한 비만 치료 경과 후 다시 추적한 결과 체중 감량과 간효소 수치의 개선 경향을 보인 10예를 보고하였다. 본 연구를 토대로 한약 치료를 포함한 한방 비만치료 시 유효성과 안전성에 대한 근거를 더 확보해나갈 수 있을 것으로 생각된다.

Many obesity patients were affected by depressed liver function including hepatosteatosis. The aim of this study was to investigate the clinical effect of the obesity therapy with Korean herbal medicine (KHM) on obese patient with abnormal liver function. This is a retrospective observational study performed on obesity patients with abnormal liver function. All subjects have taken serum liver function tests (LFTs) before treatment. Ten patients showed abnormal LFTs. They were treated with KHM at least 15 days. During this treatment, LFTs were evaluated afterwards. Body weight and body mass index of the patients were decreased during treatments. Five of 10 subjects recovered normal levels of LFTs. While other subjects remained at abnormal level but their levels were decreased. This study shows that the obesity therapy including KHM could be effective to improve liver function on obese patient. Additional large scale studies are necessary for more evidences.

키워드

참고문헌

  1. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA. 1997 ; 94(6) : 2557-62. https://doi.org/10.1073/pnas.94.6.2557
  2. Park BJ. Herbal diet of obese with osteoarthritis. J Korean Med Obes Res. 2004 ; 4 : 201-11.
  3. Kim GS, Kim DY. A case report for a obese patient accompanied with hypertension, dyslipidemia and osteoarthritis. J Korean Med Obes Res. 2001 ; 1 : 12-20.
  4. Kim DH, Oh DS, Shin SU, Shin HT. A case report for the effects of the modified fasting therapy (Gamrosu) on obese patients with hypertension. J Korean Med Obes Res. 2016 ; 16(1) : 70-7. https://doi.org/10.15429/jkomor.2016.16.1.70
  5. Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption and liver enzyme activity-a 4 year follow-up study. Int J Epidemiol. 2001 ; 30(4) : 766-70. https://doi.org/10.1093/ije/30.4.766
  6. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000 ; 136(6) : 727-33. https://doi.org/10.1016/S0022-3476(00)24645-3
  7. Jun DW. Non-alcoholic fatty liver disease. Clin Mol Hepatol. 2011 ; 17(3) : S332-6.
  8. Heo JK, Hwang DS, Lee CH, Lee KS. A case study on a non-alcoholic fatty liver disease (NAFLD) patient improved by the oriental obesity therapy program. J Korean Med Obes Res. 2007 ; 7(2) : 85-94.
  9. Jin YH, Kim KS, Han IY, Lee HB. Influence of prescribed Gamitaeeumjowi-tang on liver function: prospective singlecenter pilot study. J Soc Korean Med Obes Res. 2010 ; 10(1) : 29-40.
  10. Hur JI, Choi BH, Kim DW, Park K, Kim DJ, Byun JS. Case of oriental obesity treatment's effect on improvement of nonalcoholic steatohepatitis patient's liver function. Korean J Orient Physiol Pathol. 2006 ; 20(6) ; 1785-8.
  11. Kim KY. Effects of Taeumin, Soeumin and Soyangin prescriptions on the adipocyte induced by gold thioglucose in the rat. J Const Med. 1996 ; 8(1) : 295-317.
  12. Yoon JH, Ryu SH, Jeong KH, Choi DG, Jeong IK, Lee HH, et al. Effects of 12 weeks Taeyeumjoweetang administration on enzymes and fat accumulation in rat liver cells. Exerc Sci. 2002 ; 11(1) : 53-65.
  13. Hwang MJ, Shin HD, Song MY. Review of literature on herbal medicines for the treatment of obesity in Korea: mainly papers since 2000. J Orient Rehab Med. 2006 ; 16(3) : 65-81.
  14. Kim DY, Kim GS. The effect of very low calorie diet and Chegameuiintang on body composition in obese patients. J Korean Med Obes Res. 2001 ; 1 : 1-14.
  15. Ryu SM, Jung SH, Lee JS, Kim SS, Shin HD. The effect of very low calorie diet and Chegamuiyiin-tang on bone mineral density. J Korean Med Obes Res. 2005 ; 5(1) : 87-95.
  16. Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000: mainly about Ephedra Herba. J Korean Med Obes Res. 2007 ; 7(1) : 39-54.
  17. Seung HS, Park SM, Han CW, Kim YC, Lee JH, Woo HJ. Two cases of hepatitis treated with Gagamsaenggan-tang. Korean J Orient Int Med. 2002 ; 23(2) : 229-37.
  18. Park SM, Lee JH, Seung HS, Kim YC, Lee JH, Woo HJ. A case of Gagamsaenggan-tang's effect on non alcoholic steatohepatitis. J Korean Orient Chronic Dis. 2001 ; 7(1) : 73-7.
  19. Lee JH, Park SM, Kim YC, Woo HJ. A clinical study of the effects of Chungganhaeju-tang on alcoholic fatty liver. J Korean Orient Med. 2001 ; 22(4) : 107-13.
  20. Lee JE, Lee JH. Experimental study of Chungganhaeju-tang (Qingganjiejiu-tang) on oxidative stress. Korean J Orient Int Med. 2011 ; 32(2) : 188-202.

피인용 문헌

  1. 최근 10년간 한방비만학회지의 연구동향 분석: 2010-2019년 한방비만학회지 게재논문을 중심으로 vol.20, pp.2, 2017, https://doi.org/10.15429/jkomor.2020.20.2.149
  2. 한약복용이 간기능에 미치는 영향 : 국내 문헌에 대한 체계적 고찰 vol.41, pp.6, 2020, https://doi.org/10.22246/jikm.2020.41.6.933